about
IDH1 and IDH2 mutations in gliomasTo BRAF or not to BRAF: is that even a question anymore?IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.2-Hydoxyglutarate: D/Riving Pathology in gLiomaSAssessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibodyImmunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastasesMonoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482WDetection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomasLow rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas.1p/19q testing has no significance in the workup of glioblastomas.Genetic characterization of gliomas arising in patients with multiple sclerosis.GABA-A channel subunit expression in human glioma correlates with tumor histology and clinical outcome.Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma.Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomasPapillary glioneuronal tumor--a rare entity: report of four cases and brief review of literature.Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinaseAccumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy.A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.Subclassification of newly diagnosed glioblastomas through an immunohistochemical approach.Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markersPROX1 is a predictor of survival for gliomas WHO grade IIProximity ligation assay evaluates IDH1R132H presentation in gliomasIDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resectionManagement of high-grade gliomas in the pediatric patient: Past, present, and future.A protein-targeting strategy used to develop a selective inhibitor of the E17K point mutation in the PH domain of Akt1.How molecular testing can help (and hurt) in the workup of gliomas.Emerging insights into the molecular and cellular basis of glioblastoma.Glioma Cells in the Tumor Periphery Have a Stem Cell PhenotypeClonal analysis in recurrent astrocytic, oligoastrocytic and oligodendroglial tumors implicates IDH1- mutation as common tumor initiating event.The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas.Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort.Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation.The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor MolA malignant cellular network in gliomas: potential clinical implications.Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomasTreatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.What do we know about IDH1/2 mutations so far, and how do we use it?Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing.Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas
P2860
Q24561928-2EBAC20C-7928-49B4-9B8A-CF1A9E743FA1Q26829788-3270D18B-C908-4D60-88A6-F6E508EA43C4Q27692015-26B03E3F-328F-419D-BC34-EF0C54E81F7EQ28087807-0BEDB6A7-3C4D-4333-9E38-F36DC4B71142Q28239475-E38B7133-A685-4560-8F32-6E7B5670EF13Q28250795-C276B759-5456-480E-8BFD-01F34ED94BD7Q28752198-E85042C6-1B83-40CC-B01A-88C057EE8AC6Q30664676-DFDC9A19-E776-4A65-A81E-A35CB8699A9FQ33753426-CC834DFD-1FD5-4CBD-8257-C090C57C5207Q33859265-79BD1827-29E1-4AB0-B63F-BE6C1A74170AQ33893445-B54E122E-8FF6-46E7-83FC-F277C1DFE3B1Q34252385-1BC9EC9D-2DD5-42D7-B5CE-6DC5FF5CFF80Q34277659-94607358-F2A2-4A2D-9F24-EF88F34835A1Q34359670-65B4D34A-26D2-48B0-9D06-91F68138B5F4Q34363432-405AF9D6-003C-4C4A-94A0-3F9CB384BFDAQ34368065-00C0C0AD-3F12-410E-8102-6BAC53B8A14AQ34451033-ADC8E775-673F-4121-9E54-D470DDB26F6BQ34539504-B0343E3A-69DE-4042-AA12-F1BF5361E43BQ34635517-DFEFC988-8414-4A26-B094-EDC8E4A4ED73Q34783220-7D865430-D414-4259-ADBE-C8080551EBD4Q34815207-5070D1AB-044D-4455-8AF6-FA15C316EEA5Q35034643-BCD1DE47-032A-472F-8D94-71D1F98828F0Q35056736-62436F42-1D94-4235-8BB7-E00AF29F2BD7Q35059157-880C75C6-00B7-4191-B6B4-2B5BCB75D650Q35206259-DE5EF200-32EE-4F77-8283-2E85C3FA6282Q35535218-FA0B8BC9-E6AA-474B-9D68-8B6FC235F69DQ35770275-43BD2A32-C990-49C2-8807-1AC08B098BCAQ35914897-807DC7BB-97C7-46B0-AD6F-174AA596C748Q36015831-5580D3FA-CDCE-4441-A2F7-E45AB55CD762Q36109794-4989497A-6B9A-44AF-BFA9-B403F7F7FD65Q36124843-89464443-BDB5-4B52-ABF4-F52D5953C8CFQ36140650-76C3D54C-F1AD-4C4A-9D92-84D173737166Q36401831-A335F54A-25FF-4AC4-8689-25FDC3E461A8Q36564218-AB3EE6A5-BDD4-4724-B79A-5A07562EA79AQ36705939-B7F917C9-E7FD-4ED1-B2F9-F7C4BF04F89EQ36737930-6D7E039C-0460-4B8B-8550-1A57D7DF67B9Q36759382-62647A77-37AC-4360-9396-10E6BF807625Q36788229-ACAC6271-D06C-485E-8A89-6DE5A67A0B15Q36866028-5E7D9C36-D4D2-41DD-A8A6-532CF5DA5EE9Q36925070-99B7BDD8-8108-4757-8571-54A7B8FC4F0A
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Monoclonal antibody specific for IDH1 R132H mutation.
@ast
Monoclonal antibody specific for IDH1 R132H mutation.
@en
type
label
Monoclonal antibody specific for IDH1 R132H mutation.
@ast
Monoclonal antibody specific for IDH1 R132H mutation.
@en
prefLabel
Monoclonal antibody specific for IDH1 R132H mutation.
@ast
Monoclonal antibody specific for IDH1 R132H mutation.
@en
P2093
P1476
Monoclonal antibody specific for IDH1 R132H mutation.
@en
P2093
Christian Hartmann
Hanswalter Zentgraf
Jörg Balss
P2888
P304
P356
10.1007/S00401-009-0595-Z
P577
2009-10-02T00:00:00Z